Introduction
The endometrial blood vessels form a vascular bed with a number of unusual properties. Unlike most vascular beds which maintain very constant structure and function throughout life, the endometrial vasculature alters dynamically during the relatively short time-span of the menstrual cycle. This paper will review various aspects of the structure and function of the endometrial vasculature at four different stages or conditions during the menstrual cycle. These are: vascular growth, implantation, vascular regression and menstruation. The majority of this review will be based on observations from human or primate endometrium, with the exception of the section on implantation where additional information is included from non-primate species.
Architecture of the endometrial vasculature
The overall architecture of the endometrial vasculature and microvasculature has been well described by numerous workers (Markee, 1940; Ramsey, 1982 , Ferenczy, 1987 and will be only briefly reviewed here. Blood supply to the endometrium arrives through the radial arteries, which arise from the arcuate arteries within the myometrium. After passing through the myometrial-endometrial junction the radial arteries split, to form the smaller basal arteries that supply the basal portion of the endometrium and the spiral arterioles which continue up towards the endometrial surface. The spiral arterioles, which supply the functional layer of the endometrium, have a distinctive coiled appearance that becomes more pronounced during the secretory phase of the menstrual cycle. The spiral arterioles are unusual amongst resistance arterioles, in that they lack significant elastin within the internal lamina (Ferenczy, 1987) . Each spiral arteriole provides blood to a uterine luminal surface area estimated at 4-9 mm 2 (Bartelmez, 1933) , with little or no overlap between areas. Capillaries branch from the spiral arterioles at all levels supplying the stroma and periglandular networks. Just below the endometrial surface the spiral arterioles break up into the prominent subepithelial capillary plexus. This plexus drains into a number of venules that pass down through the Telephone: +61 3 9550 5370; Fax: +61 3 9550 5389; E-mail: peter.rogers@med.monash.edu.au endometrium, collecting blood from other capillaries on the way. The numerous venules join to form veins which pass out of the endometrium into the myometrium.
The basal portion of the endometrium and its vasculature remains relatively unchanged throughout the menstrual cycle. By contrast, the functional layer of the endometrium is constantly changing in response to circulating sex steroids. The rest of this review is based on the structure and function of the blood vessels in the functional zone of the endometrium.
Growth of the endometrial vasculature
There is a substantial body of literature on the processes by which new blood vessels grow in many different experimental systems. In broad terms, new vessel growth or angiogenesis is usually divided into four main stages (Klagsbrun and D'Amore, 1991) . These are basement membrane breakdown around an existing vessel, migration of endothelial cells towards a stimulus, proliferation of the endothelial cells, and formation of the endothelial cells into a new patent tube or vessel. Experimental work on angiogenesis usually focuses on one or more of these four steps to follow the process of new blood vessel formation.
Between the end of menstruation and ovulation it has been reported that the endometrial vasculature undergoes two different growth phases. The first, which commences during menstruation, is the repair of the vascular bed (Markee, 1940) . The second is the growth of the vasculature in concert with the rest of the endometrium under the influence of oestrogen during the proliferative phase of the menstrual cycle (Ferenczy et al., 1979) . Evidence to support these earlier studies has come from an in-vitro endothelial cell migration assay which was used to evaluate the release of endothelial cell migratory signal from endometrial explants taken at all different stages of the menstrual cycle . Two peaks of endothelial cell migratory activity were identified, one immediately postmenstrually and the second in the mid-late proliferative phase of the cycle.
Based on the conventional wisdom that endothelial cell proliferation should accompany migration during angiogenesis, a subsequent study used immunohistochemical techniques to evaluate endothelial cell proliferation in a similar set of endometrial biopsies (Goodger (Macpherson) and Rogers, 1994) . This work demonstrated wide variability in endothelial cell proliferation between endometria from the same stages of the menstrual cycle, with no evidence at all for peaks of endothelial cell proliferation either post-menstrually or in the mid-late proliferative phase of the cycle, although high levels of endothelial cell proliferation could be found at all stages of the cycle. This result suggests that endothelial cell migration and proliferation are controlled independently during endometrial angiogenesis. If correct, this finding demonstrates that the physiological growth of new blood vessels in the endometrium does not follow exactly the conventionally accepted steps of the angiogenic process. This finding has significant implications for our understanding of how angiogenesis might be controlled in the endometrium, and which angiogenic cytokines may be involved.
That endometrial angiogenesis is a tightly controlled process is demonstrated by the fact that vascular density in the endometrium remains constant throughout the menstrual cycle, despite the large changes in tissue growth and oedema that occur . However, while many factors known to influence the angiogenic process have been identified in endometrium, the specific mechanisms by which vascular growth is controlled remain unclear. The endometrium and its resident population of macrophages are capable of producing most, if not all, of the major cytokines and factors currently known to play a role in controlling angiogenesis (Giudice, 1994; Sunderkotter et al., 1994; Smith, 1995) . Publications investigating variations in the expression of some of these factors throughout the menstrual cycle include: vascular endothelial growth factor (VEGF) , fibroblast growth factor (FGF) (Ferriani et al., 1993) , TGF-α (Horowitz et al., 1993) , interleukin (IL)-1 and IL-6 (Tabibzadeh, 1991) , epidermal growth factor (EGF) (Haining et al., 1991) and IL-8 (Critchley et al., 1994) . However, many of these studies are preliminary in nature and since there is no clear understanding of when or how new blood vessel formation occurs in the endometrium during the menstrual cycle, there is nothing meaningful with which to correlate the reported variations in cytokine expression. In addition the pleiotrophic nature of most cytokines and the many ways in which their actions are regulated weaken the assumption that they may be specifically involved in endometrial angiogenesis. It is also important to note that endometrial expression of cytokines is usually very varied from subject to subject, and even within the same subject from cycle to cycle. Thus studies involving small groups of women need to be interpreted with caution.
Role of the endometrial vasculature in embryo implantation
Based on animal studies, it has been shown that for embryo implantation to occur the endometrium must be in a receptive state (Humphrey, 1969) . The implantation window is defined as the period of time when the uterus is receptive to the implanting blastocyst, while implantation-neutral and implantation-hostile states respectively describe times when the embryo can survive in the uterus but will not implant and when the embryo is actively destroyed (Psychoyos and Casimiri, 1980; Rogers, 1993) . Given the early and prominent role that the endometrial vasculature plays in the endometrial response to the implanting blastocyst, it seems likely that vascular changes may contribute to uterine receptivity.
In most placental mammals studied to date, a localized increase in endometrial microvascular permeability appears to be one of the first signs of impending implantation. This increase in permeability is seen across a range of implantation modes, in such species as rat (Psychoyos, 1960; Rogers et al., 1983) , guinea-pig (Deansley, 1967) , sheep (Boshier, 1970) and pig (Keys et al., 1986) . Despite the ubiquitous nature of this endometrial microvascular response to the implanting embryo, there is still little understanding of either the mechanisms responsible, or the underlying physiological reasons. Whether an equivalent increase in vascular permeability occurs in humans is unknown. Oedema is visible around the human implantation site by day 9 post-ovulation (Hertig et al., 1956) , although this is probably later in the implantation process than that reported above for other mammalian species.
Using vascular corrosion casting/scanning electron microscope techniques it has been possible to demonstrate major changes in endometrial microvascular architecture in the rat at the time of the blastocyst-induced increase in permeability (Rogers et al., 1982) which has usually begun by the evening of day 5 of pregnancy. The blood vessel network within each implantation site becomes widely spaced compared with other regions of the endometrium. It was suggested that, in polytocous species at least, this localized tissue hydration and vascular spacing results in differential uterine elongation that assists in the even distribution of implantation sites along each uterine horn.
Vascular corrosion casts of rat implantation sites also revealed that by 09:00 on the morning of day 6 of pregnancy there is an absence of endometrial capillaries surrounding the blastocyst, resulting in an avascular zonẽ 420 µm long by 210 µm in diameter (Rogers et al., 1983) . Subsequent histological studies showed that the avascular region corresponded to the primary decidual zone surrounding the blastocyst, and that fluorescein isothiocyanate (FITC)-tagged albumin that had leaked into the surrounding tissues due to locally increased vascular permeability did not pass between the tightly packed primary decidual cells. It seems paradoxical that the highly metabolically active embryo is isolated from maternal sources of oxygen and nutrition at this critical stage of its development. It should be noted, however, that after compaction the developing embryo acquires an increased capacity for anaerobic lactic acid metabolism (Gardner and Leese, 1988) . Two suggestions as to why maternal blood supply to the blastocyst is reduced at this critical time are that it may weaken the maternal tissues, thus enhancing trophoblast invasion, and that it may be part of the mechanism to avoid immunological rejection by the mother.
The dramatic vascular changes that occur in rat endometrium have also been shown using in-vivo microscopy to visualize the subepithelial capillary plexus during the implantation process (Tawia and Rogers, 1992 ) (see video footage on the CD-ROM). The avascular implantation site is surrounded by large diameter vessels. The capillaries closest to the embryo have an average diameter of 18.5 ± 2.5 µm, compared with 7.5 ± 0.4 µm further away from the implantation site. Blood flow through these dilated implantation site capillaries is sluggish, with frequent flow stoppages and reversals. Leukocyte adhesion and rolling is commonly seen along the walls of dilated implantation site vessels, however this rarely occurs in normal diameter capillaries distant from the implantation site. It is unclear which blastocyst-induced local mechanisms may be causing this very specific capillary dilatation, and what its significance in the implantation process may be.
Endothelial cell proliferation has been assessed using immunohistochemical methods, around the time of embryo implantation in the rat endometrium (Goodger (Macpherson) and Rogers, 1993) . Endothelial cells begin to proliferate from day 3 of pregnancy, increasing in numbers throughout the entire endometrium until embryo implantation on day 5, after which time endothelial cell proliferation proceeds at embryo sites only. In endometrial zones between embryo implantation sites, endothelial cell proliferation falls back to basal levels. These results show that endothelial cell proliferation is maternally controlled before implantation, and embryo-mediated after implantation.
Studies in humans have demonstrated that endometrial blood flow rises during the proliferative phase of the cycle, to reach a peak just before ovulation (reviewed by Fraser and Peek, 1992) . It has been shown that there is a significant positive correlation between unopposed circulating oestradiol levels and rate of endometrial blood flow. When progesterone levels are elevated, the correlation between oestradiol and blood flow is lost. The mechanism by which oestrogen increases endometrial blood flow is unclear, although present thoughts favour a non-receptor-mediated mechanism, possibly involving the release of vaso-dilators such as nitric oxide.
The recent incorporation of colour Doppler processing in transvaginal transducer/probes has provided a completely new clinical mode for investigating utero-ovarian physiology.
There are now a number of reports in the literature showing that an increased uterine artery pulsatility index at the time of embryo transfer may be associated with a reduced implantation rate (Coulam et al., 1994; Steer et al., 1995) .
While it now appears that colour Doppler assessment of uterine artery flow has a role to play in determining uterine receptivity for in-vitro fertilization (IVF), a number of questions remain to be answered about exactly what arterial impedance means at the level of the endometrial microvasculature. For example, the major uterine compartment is the myometrium and not the endometrium, thus it could be assumed that the bulk of blood passing through the uterine artery never reaches the endometrium. It has also been suggested that increased resistance to blood flow, as demonstrated by an increased uterine artery pulsatility index, may represent poor uterine vascularity (Bassil et al., 1995) . However, since blood flow through a tissue is primarily controlled by contraction and dilation of the resistance arterioles, this may not necessarily be the case. Finally, it is clear that successful implantation can still occur in women with a high pulsatility index, thus raising the fundamental question as to whether uterine artery impedance represents an obligatory marker of uterine receptivity or is just a related phenomenon. Clearly, further basic and clinical research is required in this emerging area of uterine physiology.
A detailed ultrastructural investigation of human endometrial microvasculature (Roberts et al., 1992) has shown that the basement membrane surrounding endometrial capillaries is relatively loose and discontinuous in the early proliferative phase, but that it becomes more complete and complex towards the late proliferative phase. The same study showed that endothelial cells progressively differentiate towards the mid secretory phase of the cycle, although this differentiation is heterogeneous, with some cells showing significant hypertrophy. These observations confirm the variable nature of the human endometrial microvasculature during the menstrual cycle, and suggest that it may undergo specific alterations in preparation for embryo implantation.
Regression of the endometrial vasculature
Pre-decidualization of the stromal cells surrounding the spiral arterioles commences ~8-9 days after ovulation. Decidual cells have metabolic functions related either to pregnancy or, if implantation does not occur, to menstrual breakdown of the endometrium (Ferenczy, 1987) . The location of the metabolically active pre-decidual cells around the spiral arterioles suggests an intimate role for these cells in the menstrual process. A number of studies have demonstrated high levels of cytokine expression around spiral arterioles in the secretory phase of the cycle (e.g. Horowitz et al., 1993; Tabibzadeh, 1991) .
From the mid-secretory stage to the end of menstruation, human endometrium reduces in thickness from ~5-8 mm tõ 1-3 mm (Bakos et al., 1993) . While most text books indicate that this loss of endometrium is primarily due to tissue loss and shedding during menstruation, there is good evidence to support the concept that significant endometrial regression occurs prior to menstruation. Markee (1940) reported that regression occurs 2-6 days prior to the commencement of bleeding, and that it is primarily due to fluid and tissue resorption. It has also been reported that loss of ground substance or extracellular matrix from the stroma plays a major role in reducing endometrial thickness (Bartelmez, 1957) . It is well-established that the spiral arterioles reach their maximum tortuosity towards the end of the secretory phase (Ferenczy, 1987) , at the time when the endometrium is undergoing regression. Thus it seems likely that the process of endometrial regression plays a role in increasing the coiling of the spiral arterioles by forcing them to shorten as the endometrium becomes thinner.
Apoptosis, or programmed cell death, plays a key role in the homeostatic maintenance of cell numbers (Schwartzman and Cidlowski, 1993) . In human endometrium both endothelial cell density and microvascular density remain remarkably constant throughout the menstrual cycle, despite major bursts of tissue growth, large changes in tissue hydration, and highly varied endothelial cell proliferation rates and Rogers, 1994) . It thus seems likely that endothelial cell numbers are regulated not only by addition through proliferation but also by removal through apoptosis. Evidence for hormonally regulated mechanisms controlling endometrial apoptosis have recently been published (Gompel et al., 1994) , using immunohistochemistry of the protein from the proto-oncogene Bcl-2. Bcl-2, which prolongs cell survival by preventing apoptosis, is expressed primarily in gland cells during the proliferative stage, but disappears during the secretory phase. Endothelial cells were always Bcl-2-negative, although vascular smooth muscle cells from proliferative-stage small arterioles and secretory-stage spiral arterioles were positive. More recently an immunohistochemical study of Bcl-2 distribution in human endometrium concluded that it is unlikely that Bcl-2 is important in prolonging endometrial cell survival when the luteal phase is prolonged by the use of exogenous human chorionic gonadotrophin (Koh et al., 1995) . These authors made no comment about Bcl-2 distribution in relation to the endometrial vasculature.
Work in non-endometrial tissues and cells has shown that in addition to Bcl-2, which inhibits apoptosis, various homo-logues of Bcl-2 such as Bax and Bak can act to accelerate apoptosis under certain conditions. It has been suggested that the widespread tissue distribution of Bak mRNA supports the concept that apoptosis is controlled primarily by regulation of molecules such as Bcl-2 that inhibit apoptosis (Kiefer et al., 1995) . Investigation of these mechanisms in the endometrium and its vasculature is still in its infancy, despite the fact that endometrium provides an ideal human model for physiological tissue regression and apoptosis.
Ultrastructural studies (Roberts et al., 1992) have shown that in the late secretory phase of the non-pregnant cycle, the endometrial stroma and the basal lamina show widespread degeneration prior to the onset of menstruation, with reduced cell-to-cell contacts. However, by contrast the endothelial cells appear to remain relatively intact at this time. These observations suggest that the menstrual process is being driven primarily by the stromal and/or epithelial cells of the endometrium, rather than the vascular network.
Endometrial vasculature during menstruation
Most of our current understanding of the vascular events during menstruation is still based on the remarkable series of observations using intraocular endometrial transplants in the rhesus monkey published by Markee over 50 years ago (Markee, 1940) . One to 4 days prior to the onset of bleeding, venous and arterial stasis occurs, sometimes accompanied by vasodilatation. Vasoconstriction is also seen 4-24 h prior to bleeding. About 4 days prior to menstruation leukocytic infiltration of the endometrium occurs, probably mediated in part at least by an upregulation of intercellular adhesion molecule (ICAM-1) on endothelial cells of some, but not all, endometrial blood vessels (Tawia et al., 1993) . Menstrual bleeding usually commences from the wall of an arteriole or capillary once a previously constricted spiral arteriole relaxes and blood flow recommences; ~70% of blood is lost in this way. Some blood cells also leave the capillary circulation by diapedesis (~5% of blood loss), as well as by reflux from veins through previously formed breaks in the vasculature (~25% of blood loss). Blood loss from a break in the endometrial vasculature during menstruation normally only lasts for 1-2 min before ceasing due to spiral arteriole vasoconstriction.
Throughout the normal menstrual process, the vascular bed is showing signs of constant attempts to repair itself. Goodger (Macpherson) and Rogers (1994) demonstrated high levels of endothelial cell proliferation in menstrual endometrium. This agrees with the findings of CharnockJones et al. (1993) , who found high levels of mRNA for vascular endothelial growth factor in menstrual endometrium. However, there is also evidence to support the concept that endometrial blood vessels are specifically adapted for the menstrual process. It has been shown that immunostaining for von Willebrand factor in endometrial endothelial cells is significantly reduced at the time of menstruation . A number of other mechanisms and factors that influence haemostasis and vascular breakdown are also modified during menstruation, including plasminogen activator and plasminogen activator inhibitor type 1 (Gleeson, 1994) , matrix metalloproteinases (Hampton and Salamonsen, 1994) and tissue factor (Lockwood et al., 1993) . Clinically, it is well established that both prostaglandin synthesis inhibitors and antifibrinolytic agents can act to reduce menstrual blood loss in women suffering from menorrhagia (Fraser, 1994) thus identifying two further mechanisms that presumably play a central role in controlling menstruation.
Conclusion
In evolving to accommodate the processes of implantation, placentation and menstruation, the endometrial vasculature has undergone a number of complex regulatory changes. While most, if not all, of the mechanisms that regulate vascular structure and function in other tissues are evident in endometrium, these now have the additional complexity of steroidal regulation superimposed on them. Thus the cyclical changes in steroid concentrations result in major fluctuations in vascular phenomena that are typically very stable in most blood vessels. As such the endometrial vasculature provides a powerful model for studying the regulation of vascular structure and function under physiological circumstances in a readily accessible human tissue.
